These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
527 related articles for article (PubMed ID: 9527715)
1. [Tacrine]. Dávila C; Viteri C; de Castro P Rev Med Univ Navarra; 1997; 41(1):58-64. PubMed ID: 9527715 [TBL] [Abstract][Full Text] [Related]
2. [Tacrine against Alzheimer disease? Still uncertain for which patients may the treatment be beneficial]. Wallin A Lakartidningen; 1996 Jan; 93(1-2):22-4. PubMed ID: 8544526 [No Abstract] [Full Text] [Related]
3. Pharmacologic approaches to cognitive deficits in Alzheimer's disease. Peskind ER J Clin Psychiatry; 1998; 59 Suppl 9():22-7. PubMed ID: 9720483 [TBL] [Abstract][Full Text] [Related]
5. Treatment of Alzheimer's disease: an evaluation of the cholinergic approach. Lemière J; Van Gool D; Dom R Acta Neurol Belg; 1999 Jun; 99(2):96-106. PubMed ID: 10427352 [TBL] [Abstract][Full Text] [Related]
6. Maximizing function in Alzheimer's disease: what role for tacrine? Smucker WD Am Fam Physician; 1996 Aug; 54(2):645-52. PubMed ID: 8701842 [TBL] [Abstract][Full Text] [Related]
7. Effect of cholinesterase inhibitors on attention. Pepeu G; Giovannini MG; Bracco L Chem Biol Interact; 2013 Mar; 203(1):361-4. PubMed ID: 23047023 [TBL] [Abstract][Full Text] [Related]
8. Alternatives in the treatment of memory loss in patients with Alzheimer's disease. Volger BW Clin Pharm; 1991 Jun; 10(6):447-56. PubMed ID: 2065522 [TBL] [Abstract][Full Text] [Related]
9. Cognition-enhancing drugs in dementia: a guide to the near future. van Reekum R; Black SE; Conn D; Clarke D Can J Psychiatry; 1997 Jun; 42 Suppl 1():35S-50S. PubMed ID: 9220128 [TBL] [Abstract][Full Text] [Related]
10. Have cholinergic therapies reached their clinical boundary in Alzheimer's disease? Jones RW Int J Geriatr Psychiatry; 2003 Sep; 18(Suppl 1):S7-S13. PubMed ID: 12973745 [TBL] [Abstract][Full Text] [Related]
12. Rationale for combination therapy with galantamine and memantine in Alzheimer's disease. Grossberg GT; Edwards KR; Zhao Q J Clin Pharmacol; 2006 Jul; 46(7 Suppl 1):17S-26S. PubMed ID: 16809811 [TBL] [Abstract][Full Text] [Related]
13. Tacrine for Alzheimer's disease. Med Lett Drugs Ther; 1993 Sep; 35(905):87-8. PubMed ID: 8361451 [No Abstract] [Full Text] [Related]
14. Practice guidelines for the diagnosis and treatment of Alzheimer's disease in a managed care setting: Part II--Pharmacologic therapy. Alzheimer's Disease (AD) Managed Care Advisory Council. Fillit H; Cummings J Manag Care Interface; 2000 Jan; 13(1):51-6. PubMed ID: 10747691 [TBL] [Abstract][Full Text] [Related]
15. [Convulsive crisis as a possible adverse reaction to the treatment with tacrine in Alzheimer's disease]. García-Díaz JD; Fraguas C; Garcimartín C Med Clin (Barc); 1998 Sep; 111(7):279. PubMed ID: 9789247 [No Abstract] [Full Text] [Related]
16. Donepezil for Alzheimer's disease. Benjamin B; Burns A Expert Rev Neurother; 2007 Oct; 7(10):1243-9. PubMed ID: 17939763 [TBL] [Abstract][Full Text] [Related]